Today: 20 May 2026
Shopify stock price bounces, but investors keep one eye on margins and the Feb. 17 buyback start
13 February 2026
2 mins read

Shopify stock price bounces, but investors keep one eye on margins and the Feb. 17 buyback start

NEW YORK, Feb 13, 2026, 12:22 (EST) — Regular session

  • Shopify shares bounced back in Friday’s session, recovering after two days of steep declines.
  • The buyback kicks off next week. Still, cash-flow margin guidance continues to be a hurdle.
  • Investors reconsidered software stocks in an AI-dominated market, keeping tech sentiment on edge.

Shopify Inc. climbed 1.6% to $112.40 around midday Friday, bouncing after back-to-back drops—down 6.8% on Thursday, 6.7% Wednesday.

This bounce is grabbing attention, mainly because the stock has turned into something of a litmus test for how much appetite investors have left for high-growth commerce software—especially with margins likely tightening and tech stocks moving in fits and starts.

Shopify has thrown in a fresh complication: a $2 billion share buyback kicks off Feb. 17, per a recent filing. The program doesn’t have a set end date and caps repurchases at 5% of Class A subordinate voting shares.

Shopify posted a 31% jump in fourth-quarter revenue, hitting $3.672 billion. The company’s GMV—covering all goods moved on its platform—came in at $123.841 billion. Free cash flow reached $715 million for the quarter. Looking ahead, Shopify expects first-quarter revenue to climb at a low-thirties percent pace, and sees free cash flow margin landing somewhere in the low-to-mid teens. CFO Jeff Hoffmeister called the buyback a move from a “position of financial and operating strength.” SEC

The initial market response wasn’t pretty. Shopify turned in adjusted earnings of 48 cents per share, falling short of expectations after heavier spending on international growth, AI features, and marketing put pressure on profits. Investors took issue with the company’s cash-flow margin guidance, according to Reuters. “The AI era has now reached commerce,” said Shopify President Harley Finkelstein on the earnings call. He noted a 15-fold jump in orders flowing from AI-driven search queries since January 2025. Reuters

Stocks in the U.S. edged lower on Friday, wrapping up a week marked by losses. Tech shares weighed most heavily, even as softer-than-expected inflation figures for January provided some relief. “The trend in disinflation continues,” State Street Markets’ Michael Metcalfe said. Reuters

The main Canadian index took a steep hit Thursday, dragged down by tech as nerves over AI upheaval and a dimmer Fed rate cut outlook rattled investors. Shopify tumbled 6.1% in Toronto. “People are beginning to have some questions,” said Michael Sprung, president at Sprung Investment Management, flagging the scramble to separate AI winners from the rest. Reuters

Analysts haven’t wasted time. TD Cowen bumped Shopify up to “Buy” from “Hold,” sticking with the $159 target after shares slid post-earnings, pointing to valuation as the driver. TipRanks Michael Morton at MoffettNathanson got more constructive before the numbers, moving to “Buy” and raising his price target to $150. He dismissed the risk of merchants “vibe coding” their own alternatives as “effectively nonexistent.” MarketWatch

Still, there are landmines here. Should free cash flow margins fall harder than forecasts, or if those pricey software names keep taking hits as AI disruption worries persist, the buyback alone might not hold the stock up for long.

Investors now have their eyes on two things: if Shopify kicks off its buyback program once it goes live Feb. 17, and how next week’s U.S. numbers—retail sales hit Feb. 17, Fed meeting minutes land Feb. 18—might sway expectations for consumer demand and rate cuts.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 12.02.2026

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus
Next Story

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus

Go toTop